Ganciclovir and penciclovir, but not acyclovir, induce apoptosis in herpes simplex virus thymidine kinase transformed baby hamster kidney cells

Antiviral Chemistry and Chemotherapy

Volumn 12, Issue 3, 2001, Pages 175-186

  Shaw, M M ^a   Gurr W K ^a   Watts, P A ^a   Littler, E ^a   Field, H J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ACV; Apoptosis; GCV; HSVTK; PCV

Indexed keywords

ACICLOVIR; CYCLIN B1; DNA; GANCICLOVIR; PENCICLOVIR; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; THYMIDINE KINASE; DRUG DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL GROWTH; CELL STRAIN BHK; CELL TRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENCY; ENZYME BINDING; GENE TRANSLOCATION; HERPES SIMPLEX VIRUS; IMMUNOHISTOCHEMISTRY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; CELL CYCLE; CELL LINE; CELL SIZE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; FLOW CYTOMETRY; GENE THERAPY; GENETICS; HAMSTER; HERPES SIMPLEX VIRUS 1; HUMAN; KIDNEY; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACYCLOVIR; ANIMAL; APOPTOSIS; CELL CYCLE; CELL LINE, TRANSFORMED; CELL SIZE; CELL SURVIVAL; COMPARATIVE STUDY; FLOW CYTOMETRY; GANCICLOVIR; GENE THERAPY; HAMSTERS; HERPESVIRUS 1, HUMAN; HUMAN; KIDNEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THYMIDINE KINASE;

EID: 0034792704     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020101200305     Document Type: Article

References (45)

1. A Phase I study of recombinant adenovirus vector-mediated intraperitoneal delivery of herpes simplex virus thymidine kinase (HSV-TK) gene and intravenous ganciclovir for previously treated ovarian and extraovarian cancer patients
2. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene
3. Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors
4. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells
5. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: Regression of hepatic metastasis of pancreatic tumors
6. Growth factor modulation of p53-mediated growth arrest versus apoptosis
7. Evidence for distinct kinase-mediated pathways in gadd gene responses
8. Adenovirus-mediated suicide-gene therapy using the herpes simplex virus thymidine Kinase gene in cell and animal models of human prostate cancer: Changes in tumour cell proliferative activity
9. Famciclovir: Review of clinical efficacy and safety
10. Ganciclovir-sensitive acute graft-versus-host disease in mice receiving herpes simplex virus-thymidine kinase-expressing donor T cells in a bone marrow transplantation setting
11. Increased bax expression is associated with cell death induced by ganciclovir in herpes thymidine kinase gene-expressing glioma cell line
12. The 'bystander effect': Tumor regression when a fraction of the tumor mass is genetically modified
13. Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy
14. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene
15. Herpes simplex virus thymidine kinase/ganciclovir-mediated apoptotic death of bystander cells
16. An experimental application of gene therapy for human retinoblastoma
17. In situ gene therapy for adenocarcinoma of the prostate: A phase I clinical trial
18. Cell cycle dependent usage of transcriptional start sites. A novel mechanism for regulation of cyclin B1
19. Gene therapy of hepatoma: Bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir
20. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
21. GADD45 is a nuclear cell cycle regulated protein which interacts with p21Cip1
22. Suicide gene therapy for human uterine adenocarcinoma cells using herpes simplex virus thymidine kinase
23. Tissue-specific expression of HSV-tk gene can induce efficient antitumor effect and protective immunity to wild-type hepatocellular carcinoma
24. Cancer gene therapy with HSV-tk/GCV system depends on T-cell mediated immune responses and causes apoptotic death of rumor cells in vivo
25. P53, the cellular gatekeeper for growth and division
26. Acyclovir inhibition of viral DNA chain elongation of herpes simplex virus-infected cells
27. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
28. Apoptosis or necrosis for tumor immunotherapy: What's in a name?
29. Introduction of the herpes simplex virus thymidine kinase gene into mouse cells using virus DNA or transformed cell DNA
30. Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration
31. Curability of turnouts bearing HSVTK genes transferred by retroviral vectors
32. Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene
33. In vivo retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for adult T cell leukaemia in a rat model
34. Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control
35. The safety of famciclovir in patients with herpes zoster
36. Similarities and differences in the genotoxic and apoptosis-inducing capacity of ganciclovir and penciclovir, respectively, in HSVTK+ transfectants of Chinese hamster ovary cells
37. Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: Comparison of ganciclovir, penciclovir and aciclovir
38. Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy
39. The bystander effect in the HSVtk/ganciclovir system and its relationship to gap junctional communication
40. Preclinical toxicology profile of acyclovir: An overview
41. The differentiation primary response gene, MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1
42. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir
43. GADD45 induction of a G2/M cell cycle checkpoint
44. S- and G2 phase cell cycle arrests and apoptosis induced by ganciclovir in murine melanoma cells transduced with herpes simplex virus thymidine kinase
45. Cell death: The significance of apoptosis